Court upholds big damages award to Ventas in HCP case

Share this article:
Ventas CEO Debra Cafaro
Ventas CEO Debra Cafaro
Ventas has once again won a legal victory, with a federal appeals court upholding a $101.6 million damages award in its favor against HCP Inc.

The U.S. Court of Appeals for the Sixth Circuit unanimously ruled in favor of Ventas in May. In June, HCP said it filed a petition for a rehearing of the verdict in the case, and Ventas in turn said it would “vigorously oppose” the request.

In a battle between two huge real estate investment trusts, Ventas accuses HCP of driving up the price of Sunrise Senior Living REIT, which the former purchased for $1.8 billion in 2007. Both companies were in a second round of bidding on Sunrise, but negotiations broke down between HCP and Sunrise before the final bid deadline. Ventas then went public in January 2007 with a bid at $15 per unit to buy Sunrise. Shortly afterward, HCP submitted a bid at $18 per share, but it put several conditions on the purchase. Ventas then increased its original bid to $16.50 and subsequently closed the deal.

In May 2007, Ventas filed against HCP, asserting claims of “tortious interference” with contract and prospective advantage. In order to prove tortious interference, Ventas had to prove it had a reasonable likelihood of getting Sunrise at $15 a unit; that HCP knew about the probable acquisition; that HCP intentionally interfered with the acquisition at $15 a unit; that the interference then prevented Ventas from getting Sunrise at $15 a unit; and that this was a substantial factor in damages to Ventas.

In upholding the 2009 jury verdict, Court of Appeals Judge Eric Clay wrote HCP's conduct “casts further doubt on the genuineness of its offer,” noting that HCP never sent Sunrise a signed, unconditional offer. The court also ruled for a trial solely to determine if HCP should have to pay punitive damages.
Share this article:
close

Next Article in News

More in News

Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show

Nursing home antipsychotic use has dipped nearly 19% ...

The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.

Jimmo succeeds in getting Medicare coverage, two years after landmark case ended

Glenda Jimmo has reached a settlement with the federal government and will finally receive Medicare coverage for claims that were denied in 2007, which led her to file a class-action lawsuit over the so-called "improvement standard."

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...